Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ophthotech Corp (OPHT)

Ophthotech Corp (OPHT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ophthotech Corp ONE PENN PLAZA 19TH FLOOR NEW YORK NY 10119 USA

www.ophthotech.com P: 212-845-8200

Description:

Ophthotech Corporation is a biopharmaceutical company. It is focused on developing and commercializing novel therapies for the treatment of diseases of the eye. The Company is developing Fovista and ARC1905, which are under clinical trials, for the treatment of wet AMD. Ophthotech Corporation is headquartered in New York.

Key Statistics

Overview:

Market Capitalization, $K 57,577
Shares Outstanding, K 41,422
Annual Sales, $ 0 K
Annual Net Income, $ 63,090 K
60-Month Beta 1.49
% of Insider Shareholders 3.00%
% of Institutional Shareholders 45.39%
Float, K 40,179
% Float 97.00%

Growth:

1-Year Return -48.13%
3-Year Return -97.22%
5-Year Return -95.73%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 73.66%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/08/19
Earnings Per Share ttm -1.31
EPS Growth vs. Prev Qtr -29.27%
EPS Growth vs. Prev Year -103.85%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

OPHT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -141.53%
Return-on-Assets % -41.88%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.46
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar